Loading…
The risk of acute cholangitis after endoscopic stenting for malignant hilar strictures: A large comprehensive study
Background and Aim Endoscopic stenting for unresectable malignant hilar biliary strictures (MHBS) remains challenging. Post‐endoscopic retrograde cholangiopancreatography cholangitis (PEC) can be the most common and fatal adverse event. In the present study, we aimed to systematically evaluate the i...
Saved in:
Published in: | Journal of gastroenterology and hepatology 2020-07, Vol.35 (7), p.1150-1157 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background and Aim
Endoscopic stenting for unresectable malignant hilar biliary strictures (MHBS) remains challenging. Post‐endoscopic retrograde cholangiopancreatography cholangitis (PEC) can be the most common and fatal adverse event. In the present study, we aimed to systematically evaluate the incidence, severity, risk factors, and consequences of PEC after endoscopic procedures for advanced MHBS.
Methods
Of 924 patients, we identified 502 patients with MHBS (Bismuth types II to IV) who underwent endoscopic stenting as the primary therapy at two centers over 16 years. PEC and its severity were verified according to the current Tokyo guidelines.
Results
A total of 108 patients (21.5%) experienced acute PEC. Mild, moderate, and severe cholangitis were encountered in 51 (10.1%), 42 (8.4%), and 15 (3.0%) patients, respectively. Multivariate analyses showed that metal stenting (verse plastic stenting) (OR 0.328, 95% CI 0.200–0.535, P |
---|---|
ISSN: | 0815-9319 1440-1746 |
DOI: | 10.1111/jgh.14954 |